The Food and Drug Administration Friday released an to help clinicians screen patients for potential drug interactions before prescribing the Pfizer antiviral pill Paxlovid to treat mild to moderate COVID-19 in patients at high risk for progressing to severe disease.  prescribers should review each patient’s medications and use resources noted in the checklist to evaluate for potential drug interactions in patients whose medications are not included in the checklist or . 

In other news, it may launch a pilot program for approved medical devices sterilized using radiation to help advance alternative ways to sterilize these devices.
 

Related News Articles

Headline
The Senate Finance Committee Feb. 4 voted 14-13 to advance Robert F. Kennedy Jr.’s nomination for secretary of the Department of Health and Human Services. A…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Disease Control and Prevention is reminding clinicians and other health care workers to take necessary steps to keep themselves and their…
Chairperson's File
Autumn is here, and that means cooler weather and also the start of flu season.We know the best way to prevent influenza is to get a flu vaccine. The Centers…
Headline
The National Foundation for Infectious Diseases Sept. 25 released a survey showing that less than one in five U.S. adults are concerned about themselves or a…